4.5 Article

A Novel Deep Learning Radiomics Model to Discriminate AD, MCI and NC: An Exploratory Study Based on Tau PET Scans from ADNI

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Molecular subtyping of diffuse gliomas using magnetic resonance imaging: comparison and correlation between radiomics and deep learning

Yiming Li et al.

Summary: In this study, predictive models based on radiomics and deep convolutional neural network (DCNN) were developed to preoperatively predict the molecular subtypes of diffuse gliomas. The DCNN models outperformed radiomics models in terms of accuracy and area under the curve (AUC) in most tasks, both in the training and validation sets. Therefore, DCNN models demonstrated superior performance in predicting molecular subtypes of diffuse gliomas compared to radiomics models.

EUROPEAN RADIOLOGY (2022)

Article Computer Science, Interdisciplinary Applications

Multi-View Separable Pyramid Network for AD Prediction at MCI Stage by 18F-FDG Brain PET Imaging

Xiaoxi Pan et al.

Summary: This paper presents a deep network for identifying MCI patients who will develop into AD at an early stage. By learning representations from different views of PET scans and combining them to make decisions, the proposed method shows better performance in predicting AD progression.

IEEE TRANSACTIONS ON MEDICAL IMAGING (2021)

Review Biochemical Research Methods

Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases

Nicole Campese et al.

Summary: The misfolding and accumulation of tau protein are critical pathophysiological processes in Alzheimer's disease and other neurodegenerative disorders. Tau biomarkers have been incorporated into the diagnostic criteria for AD, but their role in other NDDs remains controversial. Recent advances suggest that exploring alternative matrices for tau biomarker assessment and developing ultrasensitive techniques are crucial for AD biomarker research. Additionally, novel tau isoforms or proteolytic fragments may serve as candidate diagnostic and prognostic biomarkers for NDDs, aiding in disease progression monitoring..CompilerServices like protein misfolding amplification assays and tau-PET may offer breakthroughs in the stratification and tracking of NDDs evolution. Further studies are needed to explore the application of tau-PET outside the AD-spectrum.

EXPERT REVIEW OF PROTEOMICS (2021)

Article Clinical Neurology

Prediction of the progression from mild cognitive impairment to Alzheimer's disease using a radiomics-integrated model

Zhen-Yu Shu et al.

Summary: This study successfully predicted the progression of MCI patients to AD using a whole-brain radiomics model, with APOE4, clinical dementia rating, AD assessment scale, and radiomics signature being identified as independent predictors. The integrated model demonstrated high accuracy and specificity in the training and test sets, with the most significant predictive efficacy in identifying MCI progression to AD.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)

Article Mathematical & Computational Biology

A New-Style Random Forest Diagnosis Model for Alzheimer's Disease

Haijing Sun et al.

JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS (2020)

Review Radiology, Nuclear Medicine & Medical Imaging

Radiomics and Deep Learning from Research to Clinical Workflow: Neuro-Oncologic Imaging

Ji Eun Park et al.

KOREAN JOURNAL OF RADIOLOGY (2020)

Article Computer Science, Information Systems

Using Deep CNN with Data Permutation Scheme for Classification of Alzheimer's Disease in Structural Magnetic Resonance Imaging (sMRI)

Bumshik Lee et al.

IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS (2019)

Review Biochemistry & Molecular Biology

When Does Alzheimer′s Disease Really Start? The Role of Biomarkers

Ana Lloret et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

Article Computer Science, Artificial Intelligence

Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease

Donghuan Lu et al.

MEDICAL IMAGE ANALYSIS (2018)

Review Radiology, Nuclear Medicine & Medical Imaging

Overview of deep learning in medical imaging

Kenji Suzuki

RADIOLOGICAL PHYSICS AND TECHNOLOGY (2017)

Article Computer Science, Hardware & Architecture

ImageNet Classification with Deep Convolutional Neural Networks

Alex Krizhevsky et al.

COMMUNICATIONS OF THE ACM (2017)

Article Clinical Neurology

Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease

Keith A. Johnson et al.

ANNALS OF NEUROLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiomics: Images Are More than Pictures, They Are Data

Robert J. Gillies et al.

RADIOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiomics: the process and the challenges

Virendra Kumar et al.

MAGNETIC RESONANCE IMAGING (2012)

Article Medicine, General & Internal

Mild cognitive impairment as a diagnostic entity

RC Petersen

JOURNAL OF INTERNAL MEDICINE (2004)

Article Clinical Neurology

Mild cognitive impairment represents early-stage Alzheimer disease

JC Morris et al.

ARCHIVES OF NEUROLOGY (2001)